Literature DB >> 18991663

Focus on the role of Glutamate in the pathology of the peripheral nervous system.

Valentina Carozzi1, Paola Marmiroli, Guido Cavaletti.   

Abstract

The role of Glutamate (Glu), one of the major excitatory neurotransmitters in the central nervous system, has been thoroughly investigated in animal models and in humans in several physiologic events, such as brain development and synaptic plasticity, but also in acute and chronic neurologic diseases and psychiatric disorders. Recently, it has been demonstrated that Glu is important for sensory input transduction, particularly along the nociceptive pathway. Glu involvement in peripheral neuropathies has also been suggested on the basis of experimental studies in animals, thus widening the spectrum of possible sites of action of this neurotransmitter from the central to the peripheral nervous system. This rather unexpected observation may have important therapeutic implications, provided that a complete characterization of the glutamatergic system in the peripheral nervous system is achieved and its changes under the different pathological conditions are investigated. This review will focus on the most recent advances in the research into the role of Glu and the glutamatergic system in the pathology of the peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991663     DOI: 10.2174/187152708786441876

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  12 in total

Review 1.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

2.  Inhibition of inflammatory pain by activating B-type natriuretic peptide signal pathway in nociceptive sensory neurons.

Authors:  Fang-Xiong Zhang; Xing-Jun Liu; Li-Qin Gong; Jun-Ru Yao; Kai-Cheng Li; Zi-Yan Li; Li-Bo Lin; Ying-Jin Lu; Hua-Sheng Xiao; Lan Bao; Xiao-Hui Zhang; Xu Zhang
Journal:  J Neurosci       Date:  2010-08-11       Impact factor: 6.167

3.  Activation of the TREK-1 Potassium Channel Improved Cognitive Deficits in a Mouse Model of Alzheimer's Disease by Modulating Glutamate Metabolism.

Authors:  Fang Li; Shu-Ning Zhou; Xin Zeng; Zhen Li; Rui Yang; Xue-Xi Wang; Bin Meng; Wei-Lin Pei; Li Lu
Journal:  Mol Neurobiol       Date:  2022-06-09       Impact factor: 5.682

4.  Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat.

Authors:  Valentina A Carozzi; Alessia Chiorazzi; Annalisa Canta; Rena G Lapidus; Barbara S Slusher; Krystyna M Wozniak; Guido Cavaletti
Journal:  Neurotox Res       Date:  2009-09-15       Impact factor: 3.911

5.  Pharmacokinetics and pharmacodynamics of the glutamate carboxypeptidase II inhibitor 2-MPPA show prolonged alleviation of neuropathic pain through an indirect mechanism.

Authors:  James J Vornov; Krystyna M Wozniak; Ying Wu; Camilo Rojas; Rana Rais; Barbara S Slusher
Journal:  J Pharmacol Exp Ther       Date:  2013-06-17       Impact factor: 4.030

6.  Nerve injury-induced changes in Homer/glutamate receptor signaling contribute to the development and maintenance of neuropathic pain.

Authors:  Ilona Obara; Scott P Goulding; Jia-Hua Hu; Matthias Klugmann; Paul F Worley; Karen K Szumlinski
Journal:  Pain       Date:  2013-04-02       Impact factor: 6.961

7.  Endogenous PI3K/Akt and NMDAR act independently in the regulation of CREB activity in lumbosacral spinal cord in cystitis.

Authors:  Jarren C Kay; Chun-Mei Xia; Miao Liu; Shanwei Shen; Sharon J Yu; Chulwon Chung; Li-Ya Qiao
Journal:  Exp Neurol       Date:  2013-10-30       Impact factor: 5.330

8.  Botulinum neurotoxin type A modulates vesicular release of glutamate from satellite glial cells.

Authors:  Larissa Bittencourt da Silva; Jeppe Nørgaard Poulsen; Lars Arendt-Nielsen; Parisa Gazerani
Journal:  J Cell Mol Med       Date:  2015-03-05       Impact factor: 5.310

9.  Evidence for glutamate as a neuroglial transmitter within sensory ganglia.

Authors:  Ling-Hsuan Kung; Kerui Gong; Mary Adedoyin; Johnson Ng; Aditi Bhargava; Peter T Ohara; Luc Jasmin
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

10.  Endogenous BDNF augments NMDA receptor phosphorylation in the spinal cord via PLCγ, PKC, and PI3K/Akt pathways during colitis.

Authors:  Miao Liu; Jarren C Kay; Shanwei Shen; Li-Ya Qiao
Journal:  J Neuroinflammation       Date:  2015-08-20       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.